Evidence map›Paper›PMID 34766658›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2022

Spontaneous Graft-Induced Dyskinesias Are Independent of 5-HT Neurons and Levodopa Priming in a Model of Parkinson's Disease.

Emma L Lane, David J Harrison, Elena Ramos-Varas, Rachel Hills, Sophie Turner, Mariah J Lelos

Open access · hybridAbstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Emma L LaneSchool of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, United Kingdom.
David J HarrisonBrain Repair Group, School of Biosciences, Cardiff University, Cardiff, United Kingdom.
Elena Ramos-VarasBrain Repair Group, School of Biosciences, Cardiff University, Cardiff, United Kingdom.
Rachel HillsBrain Repair Group, School of Biosciences, Cardiff University, Cardiff, United Kingdom.
Sophie TurnerBrain Repair Group, School of Biosciences, Cardiff University, Cardiff, United Kingdom.
Mariah J LelosSchool of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, United Kingdom.ORCID 0000-0001-7102-055X
Cardiff University · GB

Funding

Medical Research Council MR/R00630X/1Parkinson's UK F-1502
6 · The paper itself

Abstract

backgroundThe risk of graft-induced dyskinesias (GIDs) presents a major challenge in progressing cell transplantation as a therapy for Parkinson's disease. Current theories implicate the presence of grafted serotonin neurons, hotspots of dopamine release, neuroinflammation and established levodopa-induced dyskinesia.

objectiveTo elucidate the mechanisms of GIDs.

methodsNeonatally desensitized, dopamine denervated rats received intrastriatal grafts of human embryonic stem cells (hESCs) differentiated into either ventral midbrain dopaminergic progenitor (vmDA) (n = 15) or ventral forebrain cells (n = 14).

resultsOf the eight rats with surviving grafts, two vmDA rats developed chronic spontaneous GIDs, which were observed at 30 weeks post-transplantation. GIDs were inhibited by D

conclusionsThese findings argue against current thinking that rats do not develop spontaneous GID and that serotonin neurons are causative, rather indicating that GID can be induced in rats by hESC-derived dopamine grafts and, critically, can occur independently of both previous levodopa exposure and grafted serotonin neurons. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Indexed as

Dyskinesia, Drug-InducedDyskinesiasParkinson DiseaseAnimalsAntiparkinson AgentsDopamineHumansLevodopaNeuronsRatsRats, Sprague-DawleySerotoninAntiparkinson AgentsDopamineLevodopaSerotonin5-HTl-dopacell therapydopaminegraft-induced dyskinesiasmicroglianeuroinflammationParkinson's disease

Identifiers

PMID34766658
PMCPMC9208367
OpenAlexW3211941290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.